Axis Bank shares slide 6% to 52-week low: This is the BIG worry….

Shares of Axis Bank took a major hit today, January 17, shedding by 6% to touch a 52-week low. This sharp decline followed the bank’s announcement of its third-quarter results for the financial year 2024-25 (Q3FY25), leaving many investors on a cautious note.

Axis Bank Q3: Market reaction – A 52-week low

Axis Bank, which had closed at Rs 1,040.20 on Thursday (January 16), opened Friday’s session at Rs 1,006.95 on the BSE and at Rs 1,000 on NSE.

The stock continued its downward spiral, hitting an intraday low of Rs 974.45, marking its 52-week low today, during the intra-day trading session.

Also Read Why is Angel One stock price falling today? One big worry is… Monday mayhem! Nifty, Sensex close 1.4% lower; Nifty Midcap 100 nosedives 4% Share market slumps as HDFC Bank leads decline; Q3 earnings concerns weigh on investor confidence Zomato stock price is falling sharply- Here’s why…

As of 1:13 PM IST, the lender’s stock was trading at Rs 988.10 apiece, a decline of 4.81% during the intraday trading session.

Also Read: Why is Infosys falling? 4 factors worrying investors are…

Axis Bank Q3: Earnings miss market expectations

Axis Bank shares plunged after the Q3 earning. In the Q3FY25, Axis Bank reported a 3.8% increase in consolidated net profit, reaching Rs 6,304 crore. This figure, although higher than the Rs 6,071 crore reported during the same period last year, fell short of analysts expectations.

Axis Bank Q3: Brokerages view Axis Bank Q3: Kotak Institutional Equities – Buy rating as valuations too attractive

Kotak Institutional Equities is bullish, maintaining a “BUY” rating with a target price of Rs 1,500. It further in its report highlighted the bank’s 15% operating profit growth and stable net interest margin (NIM) of 3.9%.

The brokerage expects the stock’s current discount to HDFC Bank and ICICI Bank to narrow as investor confidence grows.

The private lender’s financial performance of Q3FY25 has drawn a mixed response from brokerages. Although some see long-term potential, while others highlight near-term challenges, stemming from weak growth and rising slippages.

Axis Bank Q3: Elara Securities – Retains BUY despite weak performance

Elara Securities maintains a “BUY” rating with a reduced target price of Rs 1,386,

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth